{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-18T17:18:29.289482+00:00","company":{"ticker":"CNXU","cik":2066836,"company_name":"Conexeu Sciences Inc."},"pagination":{"limit":100,"returned":4,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{},"facts":[{"fact_type":"equity_issuance","fact_key":"ba3ac93f224fdd082be8272a0a6c19c4fcf6eeb8","cik":2066836,"ticker":"CNXU","company_name":"Conexeu Sciences Inc.","filed_at":"2026-06-09T20:30:46+00:00","payload":{"action":"conversion","consideration_text":"at a price of $0.001 per share","effective_date":"2026-06-08","item_codes_triggered":["3.02"],"purchaser":"the individual who is a U.S. person","security_type":"common_stock","shares_text":"100,000 shares of common stock"},"claim":"Conexeu Sciences Inc. issued 100,000 shares of common stock of common stock to the individual who is a U.S. person for at a price of $0.001 per share.","evidence_excerpt":"On June 8, 2026, the Company issued 100,000 shares of common stock (the \" Performance Warrant Shares \") at a price of $0.001 per share upon the exercise of a like number of issued and outstanding performance common stock purchase warrants (the \" Performance Warrants \"), for gross proceeds of $100.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001062993-26-003128","anchor_url":"https://secwatch.observer/filing/0001062993-26-003128#claim-ba3ac93f224fdd082be8272a0a6c19c4fcf6eeb8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/2066836/000106299326003128/0001062993-26-003128-index.htm"},{"fact_type":"equity_issuance","fact_key":"9fa2b8a1dcb724c610866e9df9ff5d14e7d6247c","cik":2066836,"ticker":"CNXU","company_name":"Conexeu Sciences Inc.","filed_at":"2026-06-09T20:30:46+00:00","payload":{"action":"warrant_issuance","consideration_text":null,"effective_date":"2026-06-04","item_codes_triggered":["3.02"],"purchaser":"one warrant holder","security_type":"warrant","shares_text":"416,667 Incentive Warrants"},"claim":"Conexeu Sciences Inc. issued 416,667 Incentive Warrants of warrant to one warrant holder.","evidence_excerpt":"On June 4, 2026, 416,667 Incentive Warrants were issued to the one Warrant holder.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001062993-26-003128","anchor_url":"https://secwatch.observer/filing/0001062993-26-003128#claim-9fa2b8a1dcb724c610866e9df9ff5d14e7d6247c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/2066836/000106299326003128/0001062993-26-003128-index.htm"},{"fact_type":"equity_issuance","fact_key":"e355f303958ddfe1f797f0591dcd0d94687448d3","cik":2066836,"ticker":"CNXU","company_name":"Conexeu Sciences Inc.","filed_at":"2026-06-09T20:30:46+00:00","payload":{"action":"conversion","consideration_text":"gross proceeds of approximately $166,667","effective_date":"2026-06-04","item_codes_triggered":["3.02"],"purchaser":"one warrant holder","security_type":"common_stock","shares_text":"416,667 shares of common stock"},"claim":"Conexeu Sciences Inc. issued 416,667 shares of common stock of common stock to one warrant holder for gross proceeds of approximately $166,667.","evidence_excerpt":"On June 4, 2026, Conexeu Sciences Inc. (the \" Registrant \" or the \" Company \") issued 416,667 shares of common stock (the \"Warrant Shares\"), upon the exercise of a like number of issued and outstanding common stock purchase warrants (the \" Warrants \"), for gross proceeds of approximately $166,667.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001062993-26-003128","anchor_url":"https://secwatch.observer/filing/0001062993-26-003128#claim-e355f303958ddfe1f797f0591dcd0d94687448d3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/2066836/000106299326003128/0001062993-26-003128-index.htm"},{"fact_type":"governance_change","fact_key":"8807dedae86faf3e18356fe6baae6f327e93fcc1","cik":2066836,"ticker":"CNXU","company_name":"Conexeu Sciences Inc.","filed_at":"2026-05-15T20:22:21+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2026-05-11","item_codes_triggered":["5.03"],"summary_text":"Increased quorum requirement for stockholder meetings from one-twentieth to one-third of outstanding shares"},"claim":"Conexeu Sciences Inc.: Increased quorum requirement for stockholder meetings from one-twentieth to one-third of outstanding shares (effective 2026-05-11).","evidence_excerpt":"On May 11, 2026, the Board of Directors of the Company approved an amendment to the bylaws (the \" Bylaws \") of the Company in order to increase the quorum requirement for meetings of stockholders from one-twentieth (1/20) of the outstanding shares of the Company entitled to vote at any such meeting, represented in person or by proxy, to one-third (331⁄3%) of the outstanding shares of the Company entitled to vote, represented in person or by proxy.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001062993-26-002703","anchor_url":"https://secwatch.observer/filing/0001062993-26-002703#claim-8807dedae86faf3e18356fe6baae6f327e93fcc1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/2066836/000106299326002703/0001062993-26-002703-index.htm"}]}